Revance Therapeutic (RVNC) PT Lowered to $11 at Piper Sandler

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Revance Therapeutic (RVNC) PT Lowered to $11 at Piper Sandler

William Blair Reviews Revance Therapeutic (RVNC) EPS

May 13, 2024 7:04 AM EDT

William Blair analyst Tim Lugo reiterated an Outperform rating on Revance Therapeutic (NASDAQ: RVNC).

The analyst comments "Revance announced first quarter 2024 DAXXIFY revenues of $22.1 million, approximating our estimate of $22.2 million and just shy of consensus of $23.5 million. While the first quarter is typically... More